The Next Big Leader in Canada’s Massive Cannabis Space
Move over Canopy Growth, there’s another Canadian player in town trading at small-cap prices with a big board narrative that may send shares skyrocketing. Do you have this company on your radar yet?
Continue Reading

LABP Insider Trading (Landos Biopharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $30,305,826.42
Insider Selling (Last 12 Months): $0.00

Landos Biopharma Insider Trading History Chart

Landos Biopharma Share Price & Price History

▲ +0.56 (4.20%)
As of 02/24/2021 01:00 AM ET
Days: 30 | 90 | 365
Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction
They called the 2020 crash 45 days early. Nobody expects what they're predicting now...
View this shocking prediction now

Landos Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2021Perceptive Advisors LlcDirectorBuy1,250,000$16.00$20,000,000.00  
2/5/2021Konstantin PoukalovDirectorBuy27,453$11.14$305,826.42  
2/4/2021Rtw Investments, LpMajor ShareholderBuy625,000$16.00$10,000,000.00  
See Full Table
Landos Biopharma logo
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and inflammatory bowel diseases. The company also develops NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1, a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and PX-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and rheumatoid arthritis. The company was founded in 2017 and is headquartered in Blacksburg, Virginia.
Read More

Today's Range

Now: $13.88

50 Day Range


52 Week Range

Now: $13.88


142,411 shs

Average Volume

547,635 shs

Market Capitalization

$543.58 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Landos Biopharma?

Landos Biopharma's top insider investors include:
  1. Konstantin Poukalov (Director)
  2. Perceptive Advisors Llc (Director)
  3. Rtw Investments, Lp (Major Shareholder)
The Hottest Pot Stock to Watch in 2021
With industry veterans on board and a unique strategy that could position the company to becoming the premium cannabis brand in Canada, this small-cap player looks on the verge of being discovered!
Continue Reading